THE INTERNET OF BODIES (IOB)
The world is rapidly changing. The digital revolution has been increased with the coronavirus pandemic, forcing further technological innovation and development.
One thing that is set to increase is the intimate interplay between humans and gadgets, particularly in the health industry. You can thank th COVID-19 saga for assisting this shift further.
We have all heard about the Internet of Things (IoT): An emerging posthuman world of unprecedented connectivity, in which smart technology will power a new industrial revolution.
For years, this field has been a very broad spectrum. Today, however, as gadgets become more commonplace in society, sub-categories that make up the IoT world are coming to the surface.
When IoT connects with your body, this is called the Internet of Bodies (IoB).
The ‘Internet of Bodies’ is a major part of the IoT revolution that basically connects the human body to a network through devices that are ingested, implanted or connected to the body in some way.
IoB devices monitor the human body, collect health metrics and other personal information and transmit those data over the internet. You may already have devices come to mind.
At the present, there are two generations that generally encompass the Internet of Bodies world:
- Body external: These are wearable devices such as Apple Watches or Fitbits that can monitor our health.
- Body internal: These include pacemakers, cochlear implants, and digital pills that go inside our bodies to monitor or control various aspects of our health.
Behind the scenes, a third generation is coming to life with the help of emerging gadgets:
- Body embedded: The next generation of the Internet of Bodies, including embedded technology where technology and the human body are melded together and have a real-time connection to a remote machine.
Already, progress in wireless connectivity, materials and innovation, is allowing implantable medical devices (IMD) to scale and be viable in many applications.
Now, it seems as if this generation will become a major interlock of the new world digital dystopia.
By the end of this piece, the connections will be made clear.
Before then, let’s take a look at the players involved in discussions relating to this field:
Our ‘friends’, the usual suspects at the World Economic Forum, are once again at the forefront of this transformation. New information released by the body explores the capabilities of this technology:
They are heavily involved in the COVID-19 saga and also are playing a role in the IoB world?
How could this be linked? Why are they so interested in health technology?
Let’s continue by building some further context on the type of devices involved in this shift.
THE SLOW BUILD
Mainstream acceptance of invasive COVID-19 testing, or any other procedure carried out by the medical cult of scientism, doesn’t just happen overnight. There is a creeping build for everything.
A new world of genetic DNA harvesting first takes root in common medical devices, and once engrained into society, incremental ‘improvements’ are made to eventually trap the masses.
This is similar to television, smart phones and many other aspects of the Web of Control.
Now, common medical assistance technology are doing way more than simply monitoring a condition — they are also collecting, analysing and storing other parts of the human body.
Many naysayers believe that COVID-19 tests with capabilities to harvest DNA is science fiction.
A take a look at a few examples of the frontier of ‘medical science’ and what they are achieving will show you that this theory is not very far fetched at all. In fact, it’s very achievable:
A smart pill is a prominent IoB device currently in use. These pills have edible electronic sensors and computer chips in them. Once swallowed, these digital pills can collect data from organs and then send it to a remote device connected to the internet.
The first digital chemotherapy pill is now in use, combining chemotherapy drugs with a sensor that captures, records, and shares information with healthcare providers. This allows them to regarding the drug dosage and time, plus other data on rest and activity, heart rate and more.
Smart contact lenses are being developed that integrate sensors and chips that can monitor health diagnostics based on information from the eye and eye fluid. One smart contact lens in development aims to monitor glucose levels, allowing diabetics to monitor their levels without repeated pinpricks.
Taking it up a notch is Brain Computer Interface (BCI) devices, where a person’s brain is actually merged with an external device for monitoring and controlling in real-time. The ultimate goal is to help allow function of the body using brain signals, rather than normal neuromuscular pathways.
These are only a few examples. Further, not all IoB use cases are for healthcare reasons.
In one widely reported example, 50 employees of Three Square Market agreed to have an RFID microchip the size of a large grain of rice implanted. This chip allows employees to gain access to the building without a key, or pay for items with a wave of their hand at the vending machine.
Little do these people know they are unleashing a world where unregulated companies, technologies and systems gain more control over individual life — now to the point of surveilling your insides.
Oh yes, naysayers, the medical industry is certainly capable of extracting whatever they need from the human body, and we can already observe many ethical and legal concerns in the real world.
HUMAN DATA COLLECTION: CONCERNS
The medical industry, in the shadows, has been developing extensively in recent years.
Now, many of these technologies are able to capture very sensitive information about patients.
IoB devices can track, record and store users’ whereabouts, bodily functions and what they see, hear, and even think, according to WEF’s detailed paper, Shaping the Future of the Internet of Bodies:
At present, there are already many unresolved questions about who has the authority to access these data sets — and how they can use it. Could you imagine how this is now?
Data collection processes pose an inherent risk to privacy, including what’s being collected, how often, whether users provided informed consent beforehand and whether they can easily opt-out of collection or forbid companies to sell their data. This is a very grey area.
Privacy and security risks are inherently ethical issues for the individuals whose data is compromised. However, IoB raises further ethical concerns, including inequity and threats to personal autonomy.
The security challenges faced by Internet of Bodies is similar to what plagues Internet of Things generally, but there can be life and death consequences when IoB devices are involved. Additionally, IoB devices create another cyber security challenge that will need to be safeguarded from hackers.
As Internet of Bodies tech continues to grow, regulatory and legal issues have not been resolved and policies built around the proper use of the technology are playing catch up as always.
Indeed, the plague of scientism must always be approached with caution. It should come as no surprise that once again challenges face the continued rollout of advanced medical assistance.
So, how does this all relate? Well, given everything that we have now learned about the rise of medical human-machine collection, we turn our attention to the COVID-19 tests being undertaken.
Something to consider: If IoB devices already post a threat to data privacy, cybersecurity and ethics, then just why are humans trusting that COVID-19 testing wouldn’t be doing the exact same thing?
In fact, on closer examination, it seems as if so-called ‘testing’ programs being undertaken could very well be part of the largest covert genomic harvesting operation in history.
Let’s put the pieces of the puzzle together.
GENETIC HARVESTING VIA COVID TESTS?
In order for any of the COVID-19 tests to be conducted, they need to collect genetic samples from everyone. This is part of the overall testing processes in most countries.
There are four different techniques employed with COVID-19 testing: reverse transcription polymerase chain reaction (RT-PCR — the current standard test for COVID-19); loop-mediated isothermal amplification (LAMP); lateral flow; and enzyme-linked immunosorbent assay (ELISA).
Each of these tests requires the collection of your genetic material, usually through taking a sample from your upper respiratory tract. In this process, a collection swab is pushed deep into your nose, throat or nasopharynx (the space that connects the two) — collecting your cells in the process.
Other methods of collection genetic samples are sometimes employed, such as collection of blood samples, depending on the test. Testing stations then collect your personal details so that they know who the genetic sample belongs to and who to report the coronavirus test results back to.
Now, let’s take a look at a prominent IoB application, Direct-to-Consumer Genetic Testing:
Does this process sound at all familiar to you? It is in this category where COVID-19 testing lies and it is in this discovery that the connection between the IoB world and DNA harvesting is revealed.
Red Flag #1: PCR tests collect DNA
Let’s go through the entire process here. PCR tests fundamentally only work on DNA, and COVID-19 virus uses RNA as its genetic code. RNA is similar to DNA, but only has a single strand.
However, viral enzymes can now convert RNA into DNA, as was discovered decades ago. These techniques have been harnessed, along with PCR, to find unique signatures in RNA.
In this case, PCR is referred to as reverse transcription PCR, or RT-PCR.
At the lab, the sample is processed and RNA is isolated and collected. Everything else is removed.
The RNA is mixed with other ingredients: enzymes (DNA polymerase and reverse transcriptase), DNA building blocks, cofactors, probes and primers that recognize and bind to SARS-CoV-2.
The process is as follows: Using heat and enzymes, converted viral DNA strands are forced apart. Short primers of DNA matching the complementary strand of the viral DNA template stick together, functioning as an artificial start site for DNA synthesis.
Once complete, the RNA is converted to a DNA copy, and that single copy is then converted into millions of copies using PCR that can be easily detected:
It is clear that the very process of the PCR test itself is done by extracting your genetic information.
Now, consider that the ‘coronavirus’ isn’t even able to be isolated in a laboratory to begin with, it becomes quite obvious that this isn’t about collecting data to compare to a boogeyman strain.
This is about amassing a database of human genetic information, and unfortunately, participants have no way of knowing just where there DNA is ending up.
Red Flag #2: Where is this information going?
Now that we have identified just how the PCR test works, the next problem lies in what is done with collected information, where it is stored, who has access to it — and for what purposes.
Generally, after collecting your genetic information, there are a range of places where DNA is stored, including public health unit databases. These act as a centralised reporting and storage repository, as well as private companies (sometimes referred to as biobanks). Now consider this:
It would not be hard for COVID-19 tests to be passed on for other ‘research purposes’ as well. This process is officially known as surreptitious genetic testing, which generally happens when a sample containing a person’s genetic material is tested for other reasons without their knowledge.
Your information is stored beyond the original purpose and handed on to a number of characters. Much like general internet data is passed on by social media giants to third-part advertisers.
Who is safeguarding this process? Where are COVID tests going?
Those conducting the COVID-19 tests could be unwitting players in this process, truthfully acknowledging that they are only interested in analysing samples to test for the presence of the coronavirus or antibodies.
However, the pathology labs which analyse the results are just doing what they’re being paid (very well) to do, and intend to collect and analyse your genetic information for other purposes.
So, if this is a possible scenario that may be taking place, we must ask ourselves: Why?
Red Flag #3: International research programs
If you have undergone a COVID-19 test, or know someone who hask, ask the following questions: Do you know where the test results, with your unique genetic information, is being stored? Do you know who has access to them? Do you know if any third parties have access — or even backdoor access?
The Australian government website doesn’t reveal too much detail about the test on their page.
Now, if they won’t tell us just where the information is going, let’s do a little digging ourselves.
The COVID-19 Host Genetics initiative includes 127 studies in an international collaboration to investigate the ‘genomes of those infected by coronavirus’. Right.
There’s another innocent-sounding (wink) initiative underway called the International COVID-19 Data Research Alliance — co-founded and funded by Bill and Melinda Gates Foundation.
Well, there you have it. Another co-host of Event 201 and at the forefront of the eugenics agenda.
No surprises there. It seems clear that the truth is this: Agreements are being struck (without knowledge or consent) for genetic information to be shared across the world with organisations in pharmaceutical and other industries, including the vaccine business.
The only question left is: What is the agenda of mass genetic data collection?
CONNECT THE DOTS
There are many good reasons to be concerned about the harvesting of genetic information.
Your DNA is a unique marker of your identity, and it reveals many things about you, your health and your family. There are many companies who are vying to capture your DNA from the moment you are born. Some states even assemble huge banks of DNA or blood from newborns, for example.
COVID-19 is no different. This isn’t about a virus. This is about taking your most sensitive details.
Who stands to benefit?
Well, we already know Big Pharma wants your DNA. Remember, 23andMe revealed a $300 million deal with pharmaceutical giant GlaxoSmithKline that gives them access to aggregate customer data.
Calico Life Sciences, a medtech company owned by Google’s parent company, Alphabet, is the also primary research partner of Ancestry.com. These companies actively profit from data-sharing agreements with research institutes and the pharmaceutical industry.
We also know that third party sharing is common practice among companies, and this is a particular risk for your genetic information, which is being collected in the COVID-19 testing process.
Could this impact future employment opportunities? Be linked to emerging digital health cards?
Companies can use genetic test results to manage the risks for all employees, for example, by controlling the activities of those who are ‘most vulnerable’.
Businesses could also see opportunities to use genetic test results in the marketplace by tailoring insurance offerings according to genetic risk.
All of these are logical answers, however, could there be a more sinister reason?
Some have suggested human DNA is being collected so it can be reversed engineered and used against the population, through means such as vaccines and artificial intelligence development.
Could this be the case?
We have extensively detailed how medical technology drives the Epsilon Agenda — the inter-generational creation of a submissive class of genetic slaves for future control systems.
It seems to likely a combination of all points raised.
The bottom line is this: No matter the intended or actual use, mass genetic testing of populations is not only ethically and legally problematic, but forms a major pillar of the future dystopian world.
Citizens must resist this type of covert surveillance at all levels.
What are your thoughts on the points raised in this feature piece?
Be sure to leave a comment below!
The Internet of Bodies is here. This is how it could change our lives | World Economic Forum
Shaping the Future of the Internet of Bodies: New challenges of technology governance | World Economic Forum
Shedding Privacy Along with our Genetic Material | AMA Journal of Ethics
The Science Behind the Test for the COVID-19 Virus | Mayo Clinic
The Virus That Isn’t There with Jon Rappoport | TOTT News
For more TOTT News, follow us for exclusive content:
Facebook — Facebook.com/TOTTNews
YouTube — YouTube.com/TOTTNews
Instagram — Instagram.com/TOTTNews
Twitter — Twitter.com/EthanTOTT